Status
Conditions
Treatments
About
The purpose of this study is to collect a variety of clinical data and blood glucose changes using a continuous glucose monitoring device for high-risk diabetes patients (prediabetes) in order to develop a personalized diabetes prevention and management platform based on artificial intelligence model using mathematical analysis.
Full description
After being informed about the study and potential risks, all patients giving written informed consent wear a continuous glucose monitoring device ("iPro2" professional continuous glucose monitoring, MedtronicⓇ, California, USA) and smart band ("Fitbit Inspire HR", FitbitⓇ, California, USA) for 1 week.
During this period, all patients are tested oral glucose tolerance test and take a standard diet (calorie calculated) at morning.
The patient's data from this study is compared to a predicted values by mathematical analysis model for diabetes prevention.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Above 18 years old.
Prediabetes
Fasting plasma glucose : 100~125mg/dL, fasting is defined as no caloric intake for at least 8 hours.
OR
2-hour plasma glucose during 75g oral glucose tolerance test : 140 ~ 199mg/dL
OR
Glycated hemoglobin(HbA1c) : 5.7~6.4% (39-47mmol/mol)
Exclusion criteria
130 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal